Granahan Investment Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-880,203
Closed -$5.77M 195
2021
Q3
$5.77M Buy
880,203
+150,212
+21% +$1.44M 0.11% 140
2021
Q2
$11.7M Buy
729,991
+174,929
+32% +$2.42M 0.22% 102
2021
Q1
$6.87M Buy
555,062
+519,073
+1,442% +$7.96M 0.15% 121
2020
Q4
$400K Buy
+35,989
New +$270K 0.01% 190
2019
Q4
Sell
-44,729
Closed -$372K 189
2019
Q3
$372K Sell
44,729
-88,920
-67% -$971K 0.02% 175
2019
Q2
$1.67M Sell
133,649
-18,831
-12% -$266K 0.08% 151
2019
Q1
$2.33M Buy
152,480
+76,680
+101% +$1.27M 0.12% 144
2018
Q4
$1.47M Buy
75,800
+20,800
+38% +$456K 0.1% 147
2018
Q3
$1.76M Buy
55,000
+45,000
+450% +$1.37M 0.1% 162
2018
Q2
$266K Buy
+10,000
New +$272K 0.02% 197

Other funds holding STIM

Granahan Investment Management's STIM Position: Q4 2021 in Review

Granahan Investment Management sold out of Neuronetics (STIM) in Q4 2021, closing a stake of 880,203 shares — an estimated $5.77M sold.

Granahan Investment Management first reported a position in STIM in Q2 2018 and held it in 10 quarters. The position peaked at $11.7M in Q2 2021. 80 funds tracked by Wall St. Rank hold STIM as of Q4 2021.

  • Granahan Investment Management reported no remaining Neuronetics position as of Q4 2021 after selling out during the quarter.
  • Granahan Investment Management sold 880,203 Neuronetics shares in Q4 2021, an estimated $5.77M.
  • Granahan Investment Management first reported a position in Neuronetics in Q2 2018 and held it in 10 quarters.
  • Granahan Investment Management's Neuronetics position peaked at $11.7M in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Neuronetics as of Q4 2021.

Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.